Skip to Main Content (Press Enter)

Logo UNISR
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca

UNIFIND
Logo UNISR

|

UNIFIND

unisr.it
  • ×
  • Home
  • Persone
  • Pubblicazioni
  • Facoltà
  • Ambiti Di Ricerca
  1. Pubblicazioni

Point-of-care testing, near-patient testing and patient self-testing: Warning points

Articolo
Data di Pubblicazione:
2024
Citazione:
Point-of-care testing, near-patient testing and patient self-testing: Warning points / Banfi, G.; Bozic, B.; Cihan, M.; Pasalic, D.; Pennestri, F.; Plebani, M.. - In: CLINICAL CHEMISTRY AND LABORATORY MEDICINE. - ISSN 1434-6621. - 62:12(2024), pp. 2388-2392. [10.1515/cclm-2024-0525]
Abstract:
Point-of-care testing (POCT), near-patient testing (NPT) and patient self-tests (PST) are diagnostic examinations performed at the time and place of patient care. While POCT and NPT are performed and analyzed by medical professionals, PST are based on samples and parameters directly collected and analyzed by lay users. These tests are spreading both in high income countries and in low to middle income countries as they are expected to improve healthcare efficiency and equity, by saving resources, releasing pressure from hospitals and reducing logistical barriers. However, accurate multidisciplinary assessment is mandatory to ensure that what they promise is real. We reviewed some important ethical aspects, international standards and regulations. The current risks associated with alternative ways of testing are explained by the principles of respect for patient autonomy and non-maleficence. Further evidence from multidisciplinary assessment is needed to evaluate pros and cons in light of the principles of beneficence and justice. Although POCT or NPT need common regulation and accurate provider training to ensure safe and appropriate interpretation of results, PST needs even more attention as they are subject to direct patient use. Randomized controlled trails including patient education should be conducted in order to provide reliable evidence on clinical outcomes, patient acceptance and cost-effectiveness. Mandatory regulation is needed to avoid harm and EU regulation should help different countries maintain a safe use of devices in a global population of producers and users.
Tipologia CRIS:
1.1 Articolo in rivista
Elenco autori:
Banfi, G.; Bozic, B.; Cihan, M.; Pasalic, D.; Pennestri, F.; Plebani, M.
Autori di Ateneo:
BANFI GIUSEPPE
Link alla scheda completa:
https://iris.unisr.it/handle/20.500.11768/198151
Link al Full Text:
https://iris.unisr.it//retrieve/handle/20.500.11768/198151/339613/10.1515_cclm-2024-0525.pdf
Pubblicato in:
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Journal
  • Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0